Lifera

Lifera is a Saudi biomanufacturing and innovation partner wholly owned by the Public Investment Fund (PIF), working to improve Saudi Arabia's biopharma resilience and advance the goals of the Saudi National Biotechnology Strategy. The company is building world-class biomanufacturing capacity for sterile and aseptic drug product and drug substance manufacturing, serving pharmaceutical and biotech customers globally. Lifera also operates Lifera Omics, developing at-scale multiomics capabilities for high-quality genetic testing and bioinformatics research serving clinical, population health, and pharmaceutical clients.